The framework has shifted from markup to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 1.4% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are up 12%. Our forward projection puts the odds of a 10% gain over the next month near 24%. The street (1 analysts) rates it hold, with a mean price target of $62.
Green Brick Partners, Inc.
GRBK · the NYSE · USD · Market cap $3.2B · 620 employees
Green Brick Partners, Inc., the third-largest homebuilder in Dallas-Fort Worth and one of Fortune Magazine's fastest-growing companies.
PASS · Titan Ethical · score 70.0At the last full screen
2026-08-26
Screened 2026-08-26 · the tape above runs as of 22:12 UTC · 11 Sep · two dates, stated on purpose · verdict and workings shown in full · never trimmed
This name holds its markdown label.
Green Brick Partners, Inc. holds its Markdown at $73.78. The statistical read favours the sellers, held for 496 days.
| Phase | Markdown · caution |
| Quantitative state | The statistical read favours the sellers, held for 496 days |
| Price at the screen | $73.78 |
| Valuation | 11.11 trailing · 11.37 forward price to earnings |
| Values screen | PASS · score 70.0 |
| Beta | 1.80 |
Five Screens, Shown in Full
Full pass across all five screens. This security clears the Titan Ethical Standard: its business and its balance sheet both stay inside the lines.
| Test | Figure | Limit | What it means | Status |
|---|---|---|---|---|
| Business activity | Permissible | Core business clean | Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending. | Pass |
| Debt load | 12.98% | Below 33% | Interest-bearing debt is just 13.0% of its assets, well under the one-third ceiling: it does not run on borrowed money. | Pass |
| Interest-bearing cash | 0.00% | Below 33% | Cash held in interest-bearing accounts and securities is 0.0% of assets, under the one-third limit. | Pass |
| Receivables | 7.68% | Below 49% | Money owed to the company is 7.7% of assets, under the 49% limit. | Pass |
| Revenue purity | 0.00% | Below 5% | Only 0.0% of revenue comes from non-compliant sources, under the 5% line. | Pass |
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
What the Numbers Say It Is WorthThe Fair Value Range
Fair value range in USD, drawn from the 2026-08-26 screen. The gold marker is the market price at the same screen. The price runs 18.4% above the base estimate.
Reading the gap · Both our model and the Street see limited upside at this price.
Price History & ProjectionsWhere it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-08-26 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain WordsHomebuilder Looks Cheap But Cycle May Be Turning
Picture a young couple signing for their first house in Dallas just as rates stay sticky. Green Brick builds those homes across Texas, Georgia and Florida, yet its revenue has already dropped five percent while the shares sit nineteen percent above our fair value. The forward multiple of eleven point seven times earnings looks modest on the surface, but this is a cyclical business where low multiples often signal peak earnings rather than a bargain.
We pass because the numbers do not line up with any margin of safety. Profit margins sit at fifteen percent and return on equity at seventeen percent, yet growth has turned negative and only one analyst even covers the name. Ethical screens clear, which removes one objection, but the valuation gap and shrinking top line leave nothing attractive on offer.
The real risk sits in the housing cycle itself. A sharp slowdown in buyer demand or further rate pressure could compress those margins quickly, and the low multiple would then prove to be a warning rather than an entry point. Analysis, not advice.
| Forward P/E | 11.4xreasonably valued |
| Trailing P/E | 11.1xreasonably valued |
| EPS, trailing | 6.64 |
| EPS, forward | 6.49 |
| Revenue growth | -8.7%revenue is shrinking |
| Profit margin | 14.8%thin but positive margins |
| Return on equity | 16.4%a solid return on shareholder capital |
| FCF yield | 0.22% |
| Debt to equity | 0.14minimal debt: a conservative balance sheet |
| Current ratio | 7.05comfortably covers its short-term bills |
| Beta | 1.80much more volatile than the market |
| Short interest, float | 0.00% |
| 52-week range | 60.44 - 83.18 |
| Market cap | $3.2B |
| Employees | 620 |
The risks · The things to watch: it already moves more than the market on an average day.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to TradeGRBK trades on the NYSE. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
Every Entry, As Written
The framework has shifted from markdown to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 0.8% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are up 12%. Our forward projection puts the odds of a 10% gain over the next month near 24%. The street (1 analysts) rates it hold, with a mean price target of $62.
The framework reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are up 12%. Our forward projection puts the odds of a 10% gain over the next month near 24%. The street (1 analysts) rates it hold, with a mean price target of $62.
The framework reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows good risk-adjusted returns.
The framework reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows good risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
Screened names in the same industry · explore each on its own page.
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $65.26 | +7.1% | · | $1,071 | +7.1% |
| 2 months | $67.28 | +3.9% | · | $1,039 | +3.9% |
| 3 months | $64.06 | +9.1% | · | $1,091 | +9.1% |
| 6 months | $67.28 | +3.9% | · | $1,039 | +3.9% |
| 1 year | $62.30 | +12.2% | · | $1,122 | +12.2% |
| 2 years | $54.07 | +29.3% | · | $1,293 | +29.3% |
| 3 years | $55.69 | +25.5% | · | $1,255 | +25.5% |
| 5 years | $23.03 | +203.5% | · | $3,035 | +203.5% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever GRBK does next, these words stay.
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.